New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Jaguar Animal Health, Inc. (JAGX) vs Lantern Pharma Inc. (LTRN)
- Jaguar Animal Health, Inc. JAGX 0.32 −8.57%
- Lantern Pharma Inc. LTRN 0.28 −15.15%
Jaguar Animal Health, Inc. and Lantern Pharma Inc. are both Biotechnology companies. Jaguar Animal Health, Inc. and Lantern Pharma Inc. are of similar size ($4.9M and $4.7M). Lantern Pharma Inc. has negative trailing earnings, so its P/E is not meaningful; Jaguar Animal Health, Inc. trades at 0.0×. Lantern Pharma Inc. has the higher net margin (0.00% vs −181.8%) and the higher return on invested capital (0.00% vs −117.8%). Across the 14 metrics below, Jaguar Animal Health, Inc. leads on 7 and Lantern Pharma Inc. on 7.
Valuation
Profitability
| Metric | JAGX | LTRN | Biotechnology median |
|---|---|---|---|
| Gross margin | 81.47% | 0.00% | 70.18% |
| Operating margin | (91.15%) | 0.00% | 0.00% |
| Net margin | (181.84%) | 0.00% | 0.00% |
| Free cash flow margin | (25.58%) | 0.00% | 0.00% |
| Return on equity | (480.38%) | (250.59%) | (51.58%) |
| Return on assets | (120.10%) | (124.41%) | (45.91%) |
| Return on invested capital | (117.79%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack